Raymond James & Associates’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-16,961
| Closed | -$207K | – | 3837 |
|
|
2023
Q1 | $207K | Buy |
16,961
+1,272
| +8% | +$15.6K | ﹤0.01% | 3444 |
|
|
2022
Q4 | $195K | Sell |
15,689
-1,586
| -9% | -$19.7K | ﹤0.01% | 3439 |
|
|
2022
Q3 | $236K | Sell |
17,275
-277
| -2% | -$3.78K | ﹤0.01% | 3316 |
|
|
2022
Q2 | $322K | Sell |
17,552
-46
| -0.3% | -$844 | ﹤0.01% | 3171 |
|
|
2022
Q1 | $283K | Buy |
17,598
+2,757
| +19% | +$44.3K | ﹤0.01% | 3424 |
|
|
2021
Q4 | $208K | Sell |
14,841
-2,998
| -17% | -$42K | ﹤0.01% | 3644 |
|
|
2021
Q3 | $334K | Sell |
17,839
-452
| -2% | -$8.46K | ﹤0.01% | 3324 |
|
|
2021
Q2 | $381K | Sell |
18,291
-36
| -0.2% | -$750 | ﹤0.01% | 3256 |
|
|
2021
Q1 | $518K | Sell |
18,327
-956
| -5% | -$27K | ﹤0.01% | 2969 |
|
|
2020
Q4 | $630K | Sell |
19,283
-655
| -3% | -$21.4K | ﹤0.01% | 2645 |
|
|
2020
Q3 | $611K | Buy |
19,938
+1,028
| +5% | +$31.5K | ﹤0.01% | 2478 |
|
|
2020
Q2 | $308K | Buy |
18,910
+1,628
| +9% | +$26.5K | ﹤0.01% | 2888 |
|
|
2020
Q1 | $172K | Sell |
17,282
-1,151
| -6% | -$11.5K | ﹤0.01% | 3068 |
|
|
2019
Q4 | $253K | Sell |
18,433
-236
| -1% | -$3.24K | ﹤0.01% | 3166 |
|
|
2019
Q3 | $283K | Sell |
18,669
-226
| -1% | -$3.43K | ﹤0.01% | 3026 |
|
|
2019
Q2 | $372K | Sell |
18,895
-4,595
| -20% | -$90.5K | ﹤0.01% | 2854 |
|
|
2019
Q1 | $390K | Buy |
23,490
+2,676
| +13% | +$44.4K | ﹤0.01% | 2820 |
|
|
2018
Q4 | $292K | Sell |
20,814
-4,824
| -19% | -$67.7K | ﹤0.01% | 2877 |
|
|
2018
Q3 | $449K | Buy |
+25,638
| New | +$449K | ﹤0.01% | 2773 |
|